Author name: Kristen Hartman

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)

Thongchot S, Aksonnam K, Thuwajit P, Yenchitsomanus PT, Thuwajit C (2023) Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review). Int J Mol Med 52(3):81. doi: 10.3892/ijmm.2023.5284 PMID: 37477132 Objective: The authors review the mechanisms through which the multiple functions of NCL can participate in the progression of cancer. In addition, the studies […]

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review) Read More »

pHast Conjugate Videos

pHast Conjugate Videos An introduction to our pHast product line: pH-sensitive fluorescent secondary conjugates designed to fluoresce when exposed to the environment inside of a cell. Also available in Chinese | French | German | Italian | Japanese | Korean | Portuguese | Spanish Also available in Chinese | French | German | Italian |

pHast Conjugate Videos Read More »

Screening targeting agents and their cell surface biomarkers for high specificity and rapid internalization via cell death and fluorescence.

Screening targeting agents and their cell surface biomarkers for high specificity and rapid internalization via cell death and fluorescence. Ancheta L, Bouajram R, Lappi DA (2018) Society for Neuroscience, San Diego, CA. Abstract Some of the most recent successes in the treatment of cancers or research into passive immunotherapies for neurodegenerative diseases, employ the use

Screening targeting agents and their cell surface biomarkers for high specificity and rapid internalization via cell death and fluorescence. Read More »

PTGFRN as a target for antibody-drug conjugate (ADC) development in mesothelioma and medulloblastoma

Marquez J (2023) PTGFRN as a target for antibody-drug conjugate (ADC) development in mesothelioma and medulloblastoma. Univ Maryland Baltimore Thesis. Objective: To investigate the role of Prostaglandin F2 Receptor Negative (PTGFRN) regulator in cancer progression and develop an antibody-drug conjugate (ADC) targeting PTGFRN for the treatment of mesothelioma and pediatric medulloblastoma. Summary: This dissertation explores

PTGFRN as a target for antibody-drug conjugate (ADC) development in mesothelioma and medulloblastoma Read More »

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases

Metz M, Kolkhir P, Altrichter S, Siebenhaar F, Levi-Schaffer F, Youngblood BA, Church MK, Maurer M (2023) Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases. Allergy doi: 10.1111/all.15850 PMID: 37605867 Objective: Authors review the role of mast cells (MC) in the pathogenesis of chronic urticaria (CU), explore current therapeutic

Mast cell silencing: A novel therapeutic approach for urticaria and other mast cell-mediated diseases Read More »

The induction of long-term potentiation by medial septum activation under urethane anesthesia can alter gene expression in the hippocampus

Dobryakova YV, Gerasimov K, Spivak YS, Korotkova T, Koryagina A, Deryabina A, Markevich VA, Bolshakov AP (2023) The induction of long-term potentiation by medial septum activation under urethane anesthesia can alter gene expression in the hippocampus. Int J Mol Sci 24(16):12970. doi: 10.3390/ijms241612970 PMID: 37629149 Objective: To study changes in the expression of early genes

The induction of long-term potentiation by medial septum activation under urethane anesthesia can alter gene expression in the hippocampus Read More »

Emerging non-viral vectors for gene delivery

Wang C, Pan C, Yong H, Wang F, Bo T, Zhao Y, Ma B, He W, Li M (2023) Emerging non-viral vectors for gene delivery. J Nanobiotechnology 21(1):272. doi: 10.1186/s12951-023-02044-5 PMID: 37592351 Summary: This review describes the fastest-growing and efficient non-viral gene delivery vectors that include liposomes and lipid nanoparticles (LNPs), highly branched poly(β-amino ester)

Emerging non-viral vectors for gene delivery Read More »

Engineering blood-brain barrier-permeable and tumor cell-ingestible pro-proteins for glioblastoma treatment

Liu X, Si W, Zhao Z, Liu N, Yang Q, Zhou R, Zhu R, Duan S, Chen Y, Yin L (2023) Engineering blood-brain barrier-permeable and tumor cell-ingestible pro-proteins for glioblastoma treatment. Sci China Chem doi: 10.1007/s11426-023-1684-5 Objective: Using M2-D, a blood brain penetrating pro-protein, conjugated to saporin to kill glioblastoma cells in mice. Summary: M2-D,

Engineering blood-brain barrier-permeable and tumor cell-ingestible pro-proteins for glioblastoma treatment Read More »

DichroIDP: a method for analyses of intrinsically disordered proteins using circular dichroism spectroscopy

Miles AJ, Drew ED, Wallace BA (2023) DichroIDP: a method for analyses of intrinsically disordered proteins using circular dichroism spectroscopy. Commun Biol 6(1):823. doi: 10.1038/s42003-023-05178-2 PMID: 37553525 Objective: To use DichroIDP software to analyze secondary structures of proteins containing disordered structures via circular dichroism spectroscopy. Summary: Globular proteins have specific shapes and mainly contain standard

DichroIDP: a method for analyses of intrinsically disordered proteins using circular dichroism spectroscopy Read More »

Designing coiled-coil peptide materials for biomedical applications

Jorgensen MD (2023) Designing coiled-coil peptide materials for biomedical applications. Purdue University Thesis. Objective: Using saporin [PR-01] containing hydrogel to target and eliminate cancer cells. Summary: Hydrogels can bind molecular cargo and be used to shuttle cytotoxic drugs across the body. Using a pH-responsive hyaluronic acid nanogel containing saporin, cancer cells with overexpressed CD44 receptor

Designing coiled-coil peptide materials for biomedical applications Read More »

Shopping Cart
Scroll to Top